GlobeNewswire by notified

Transaktioner i henhold til aktietilbagekøbsprogram

Del

SELSKABSMEDDELELSE

A.P. Møller - Mærsk A/S – Transaktioner i henhold til aktietilbagekøbsprogram

Den 5. maj 2021 annoncerede A.P. Møller - Mærsk A/S (“Selskabet”) et aktietilbagekøbsprogram til en værdi af op til DKK 32 mia. (ca. USD 5 mia.), der vil blive opkøbt over en periode på op til to år. Den 12. august 2022 offentliggjorde Selskabet en forøgelse af det nuværende aktietilbagekøbsprogram fra DKK 32 mia. (ca. USD 5 mia.) til DKK 39,3 mia. (ca. USD 6 mia.).

Som annonceret den 3. november 2022, vil Selskabet i tredje fase af programmet, der løber fra 3. november 2022 til 3. maj 2023, købe egne A-aktier og B-aktier for et beløb op til DKK 11 mia. Tredje fase af tilbagekøbsprogrammet gennemføres i overensstemmelse med EU Kommissionens forordning nr. 596/2014 af 16. april 2014 (MAR) og EU Kommissionens delegerede forordning 2016/1052 (”Safe Harbour Regulativet”).                                                
Under aktietilbagekøbsprogrammet er der i perioden fra mandag d. 6. marts til fredag d. 10. marts foretaget følgende transaktioner:            

Antal
A aktier
Gennemsnitlig
købspris A aktier, DKK
Transaktionsværdi,
A aktier, DKK
I alt, seneste meddelelse (marked og A.P. Møller Holding A/S)274.5704.645.974.082
 6 marts mandag12016.756.83332.010.820
 7 marts tirsdag20016.422.25003.284.450
 8 marts onsdag10016.084.50001.608.450
 9 marts torsdag19715.985.68533.149.180
 10 marts fredag50015.704.96007.852.480
Total 6. -10. marts fredag1.11717.905.380
Køb fra A. P. Møller Holding A/S*1.18516.030.367718.995.986
Total i tredje fase af aktie-tilbagekøbsprogrammet (marked og A.P. Møller Holding A/S)89.9841.348.120.565
Total under aktietilbagekøbs-
programmet (marked og A.P. Møller Holding A/S)
276.8724.682.875.448
Antal
B aktier
Gennemsnitlig
købspris B aktier, DKK
Transaktionsværdi,
B aktier, DKK
I alt, seneste meddelelse (marked, A.P. Møller Holding A/S og Familiefonden)1.185.86021.031.606.180
 6 marts mandag47816.984.42478.118.555
 7 marts tirsdag80216.626.246913.334.250
 8 marts onsdag40016.279.13756.511.655
 9 marts torsdag79616.166.639412.868.645
 10 marts fredag2.00015.873.205031.746.410
Total 6. -10. marts fredag4.47672.579.515
Køb fra A. P. Møller Holding A/S*3.58916.215.481358.197.363
Købt fra Familiefonden*1.13116.215.649418.339.899
Total i tredje fase af aktie-tilbagekøbsprogrammet (marked, A.P. Møller Holding A/S og Familiefonden)361.0805.516.764.940
Total under aktietilbagekøbs-
programmet (marked, A.P. Møller Holding A/S og Familiefonden)
1.195.05621.180.722.957

*) I henhold til separate aftaler deltager A.P. Møller Holding A/S og A.P. Møller og Hustru Chastine Mc-Kinney Møllers Familiefond (Familiefonden) på pro rata basis i forhold til aktier købt under tilbagekøbsprogrammet.

Side 1 af 2

Efter ovenstående transaktioner ejer Selskabet i alt 245.040 A-aktier og 1.061.711 B-aktier som egne aktier, svarende til 6,99% af aktiekapitalen.

Detaljerede handelsoplysninger er vedhæftet som bilag.

København, 13. marts 2023

Kontaktpersoner:

Head of Investor Relations, Sarah Spray, tlf. +45 3147 4170
Head of Media Relations, Jesper Løv, tlf. +45 6114 1521

Side 2 af 2

Vedhæftede filer

For at se dette indhold fra www.globenewswire.com, så skal du give din accept på toppen af denne side.
For at se dette indhold fra ml-eu.globenewswire.com, så skal du give din accept på toppen af denne side.

Information om GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg pressemeddelelser fra GlobeNewswire by notified

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra GlobeNewswire by notified

Inteleos to Host Roundtable on Advancing Maternal Health through Point-Of-Care-Ultrasound Certification6.5.2024 23:25:48 CEST | Press release

Global healthcare certification leader convenes experts to discuss ultrasound training and certification as key strategy to reduce maternal mortality ROCKVILLE, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Inteleos, a non-profit global healthcare certification organization, will host a roundtable discussion titled "Advancing Maternal and Fetal Health through POCUS Training and Certification" on May 29 alongside a side event during the WHO World Health Assembly and the AI for Good Global Summit. The roundtable will explore the urgent need to expand point-of-care ultrasound (POCUS) training and certification for frontline maternal health clinicians as a crucial intervention for reducing preventable maternal deaths and achieving UN Sustainable Development Goals, and how to implement to scale. Despite the increased availability of affordable ultrasound technology, there remains a significant training gap that limits access to this diagnostic tool, especially in low-resource areas with high matern

ETC’s Commercial/Industrial Units Awarded Three Contracts Totaling $15.9 Million6.5.2024 22:15:00 CEST | Press release

SOUTHAMPTON, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Environmental Tectonics Corporation’s (OTC Pink: ETCC) (“ETC” or the “Company”) Sterilization Systems Group announced it has been awarded $13.9 million in contracts from two multi-national medical device manufacturers. The contracts include four, sixteen pallet ethylene oxide (“EO”) sterilization system chambers with related conveyer systems, and a large capacity vacuum drying chamber with preconditioning. “These contracts reflect ETC Sterilization Systems Group’s dedication to innovation in our mechanical designs, control systems and software expertise to meet the challenging requirements of this market,” states Eric Hunnicutt, ETC Director of EO Sterilizer Sales. ETC’s Sterilization Systems Group offers Steam and Ethylene Oxide (“EO”) Sterilizer Systems, Vacuum Dryers, Software Systems, and project management services to the Medical Device, Pharmaceutical, Biotechnology, and Life Science industries. ETC’s systems are specially design

Merus Announces U.S. FDA Acceptance and Priority Review of Biologics License Application for Zeno for the Treatment of NRG1+ NSCLC and PDAC6.5.2024 22:05:00 CEST | Press release

If approved, Zeno will be the first targeted therapy for NRG1+ cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 06, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review a Biologics License Application (BLA) for the bispecific antibody zenocutuzumab (Zeno) in patients with neuregulin 1 fusion (NRG1+) non-small cell lung (NSCLC) and NRG1+ pancreatic (PDAC) cancer. “FDA acceptance of our first BLA represents an important achievement for Merus and an important potential treatment opportunity for patients with NRG1+ cancer, a disease with poor prognosis and high unmet need,” said Dr. Andrew Joe, Chief Medical Officer at Merus. “Zenocutuzumab has the potential to be the first and only targeted therapy for patients with NRG1+ lung and

Nokia Corporation: Repurchase of own shares on 06.05.20246.5.2024 21:30:00 CEST | Press release

Nokia Corporation Stock Exchange Release 06 May 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 06.05.2024 Espoo, Finland – On 06 May 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL385,6823.45CEUX--BATE--AQEU--TQEX--Total385,6823.45 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 4 April 2023 started on 20 March 2024 and ends by 18 December 2024 with a maximum aggregate purchase price of EUR 300 million. Total cost of tra

Trading in Novo Nordisk shares by board members, executives and associated persons6.5.2024 21:02:16 CEST | Press release

Bagsværd, Denmark, 06 May 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company’s board members, executives and their associated persons have given Novo Nordisk power of attorney on their behalf to publish trading in Novo Nordisk shares by the company’s board members, executives and their associated persons. Please find below a statement of such trading in shares issued by Novo Nordisk. 1 Details of the person discharging managerial responsibilities/person closely associated a) Name of the Board member/Executive/Associated Person Novo Holdings A/S, associated to Kasim Kutay 2 Reason for the notification a) Position/status Member of the Board of Directors b) Initial notification/Amendment Initial notification 3 Details of the issuer a) Name Novo Nordisk A&S b) LEI 549300DAQ1CVT6CXN342

HiddenA line styled icon from Orion Icon Library.Eye